Aktis Oncology, Inc.
$16.11
Mkt Cap 868.5M
Biotechnology company developing alpha-particle radiopharmaceuticals (radioactive cancer drugs) for cancer treatment; no approved products yet.
aktisoncology.com ↗Summary by The Compound Family, based on the company’s own website
—
/100 Overall
Calculating score…
Running full analysis
Ready to value this company?
Run a full DCF model with Monte Carlo simulation.
Run DCF Valuation →
Run a full DCF model with Monte Carlo simulation.
Key Metrics
Loading full analysis…
Running full 6-factor analysis…